6 Results for "

NCI-H69

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "NCI-H69" in MCE Product Catalog:

Cat. No.: HY-157396
CAS No.: 2899209-55-1
Purity:  98.11%
Research Areas:  

Cancer

JAB-2485 is an orally active and selective Aurora kinase A (AURKA) inhibitor with an IC50 value of 0.327 nM. JAB-2485 exhibits inhibitory activity against various tumor cell lines such as neuroblastoma, triple-negative breast cancer, small cell lung cancer, and epithelial ovarian cancer. JAB-2485 can induce cell cycle arrest and apoptosis in tumor cells. JAB-2485 has antitumor activity .
loading...
    loading...
Cat. No.: HY-W247437
CAS No.: 1472731-41-1
Target:  

Ligands for E3 Ligase

Research Areas:  

Cancer

E3 ligase Ligand 56 is the ligand for E3 ligase Cereblon and can be used for syntheisis of PROTAC CDK9 degrader-11 (HY-170978) .
loading...
    loading...
Cat. No.: HY-P1185
CAS No.: 115150-59-9
Antagonist G is a potent vasopressin antagonist. Antagonist G is also a weak antagonist of GRP and Bradykinin. Antagonist G induces AP-1 transcription and sensitizes cells to chemotherapy .
loading...
    loading...
Cat. No.: HY-170979
CAS No.: 3039540-24-1
Research Areas:  

Cancer

CDK9 ligand 3 is the ligand for CDK9 and can be used for synthesis of PROTAC degrader PROTAC CDK9 degrader-11 (HY-170978) .
loading...
    loading...
Cat. No.: HY-P1185A
Research Areas:  

Cancer

Antagonist G TFA is a potent vasopressin antagonist. Antagonist G is also a weak antagonist of GRP and Bradykinin. Antagonist G induces AP-1 transcription and sensitizes cells to chemotherapy .
loading...
    loading...
Cat. No.: HY-181838
CAS No.: 3064485-73-7
Target:  

CDK Apoptosis

Research Areas:  

Cancer

CIRc-014 is an orally active Cyclin A/B inhibitor with a Cyclin A IC50 of 0.05 μM, Cyclin A Kd of 2.7 nM, Cyclin B IC50 of less than 0.02 μM and Cyclin B Kd of 1.0 nM. CIRc-014 activates the spindle assembly checkpoint and promotes the formation of a complex between Cyclin B and CDK2 by blocking the RxL interaction of Cyclin A/B. CIRc-014 can induce replication stress, DNA damage, mitotic arrest and apoptosis in tumor cells. CIRc-014 showed tumor growth inhibition and regression in NCI-H69 and NCI-H446 small cell lung cancer xenograft models. CIRc-014 can be used for the research of small-cell lung cancer .
loading...
    loading...